Free Trial
OTCMKTS:NCAP

Northsight Capital (NCAP) Stock Price, News & Analysis

Northsight Capital logo
$0.0001 +0.00 (+∞)
As of 07/2/2021

About Northsight Capital Stock (OTCMKTS:NCAP)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
$0.0020
Volume
71,100 shs
Average Volume
464,376 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Northsight Capital and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NCAP Stock News Headlines

Capital One Venture Rewards Card Review 2024
Next Capital PCL
Out of 18,347 Cryptocurrencies... This is the ONLY One
This Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top Fall 2025 pick sits at the center of it all...tc pixel
See More Headlines

NCAP Stock Analysis - Frequently Asked Questions

Northsight Capital's stock was trading at $0.0001 at the start of the year. Since then, NCAP stock has increased by 0.0% and is now trading at $0.0001.

Shares of NCAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Northsight Capital investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE) and Aquinox Pharmaceuticals (AQXP).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Advertising Agencies
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:NCAP
CIK
1439397
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:NCAP) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners